Unknown PHASE2 INTERVENTIONAL 4-arm NCT04359537

Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 (CHEER)

Comparative Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 in Healthcare Personnel

Sponsor: Shaheed Zulfiqar Ali Bhutto Medical University

Conditions COVID 19

Interventions Hydroxychloroquine Sulfate 200 MG Placebo

Updated 6 times since 2020 Last updated: May 16, 2020 Started: May 1, 2020 Primary completion: Aug 25, 2020 Completion: Sep 25, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates COVID 19 and is currently ongoing. Shaheed Zulfiqar Ali Bhutto Medical University leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jun 2022 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2021 — Jun 2022 [monthly]

Recruiting PHASE2
Jun 2020 — Jan 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

May 2020 — Jun 2020 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shaheed Zulfiqar Ali Bhutto Medical University

Data source: Shaheed Zulfiqar Ali Bhutto Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Islamabad, Pakistan